Morepen Laboratories Limited
Audited Financial Results
For the Quarter and Year ended 31st March, 2011
                          (Rs. in Lacs)
Sr. No. Particulars   Standalone                          Consolidated       
  Quarter ended    Year ended   Quarter ended    Year ended 
  31.03.2011 31.03.2010   31.03.2011 31.03.2010   31.03.2011 31.03.2010   31.03.2011 31.03.2010
  (Audited)   (Audited)   (Audited)   (Audited)
1(a) Net Sales/Income from Operations   5468.37 5267.60   21482.86 19592.89   5718.59 5024.81   22656.39 21156.89
(b) Other Operating Income   247.68 23.27   252.24 23.27   247.53 60.83   277.20 61.44
  Total Net Operating Income (1a+1b)   5716.06 5290.87   21735.11 19616.16   5966.13 5085.64   22933.60 21218.33
2 Expenditure                        
  a)  (Increase) / Decrease in Stock-in-Trade & Work in Progress   (80.58) (256.79)   (339.76) (504.84)   (114.62) (256.81)   (339.76) (504.84)
  b)  Consumption of Raw Materials   4008.82 3303.32   14992.53 13350.19   4088.87 3297.31   15211.90 13678.86
  c)  Employee Cost   732.65 546.33   2728.35 2162.43   856.29 605.04   3101.20 2395.44
  d) Depreciation and Amortisation   1120.24 1142.75   4578.17 4562.86   1179.91 1202.96   4815.53 4802.06
  e)  Other Expenditure   849.59 1067.18   3525.51 3248.75   970.67 1335.43   4281.27 4500.14
  Total Expenditure   6630.72 5802.79   25484.80 22819.39   6981.12 6183.93   27070.14 24871.66
3 Profit / (Loss) from Operations before Other Income, Interest and Exceptional Items (1-2)   (914.67) (511.92)   (3749.70) (3203.23)   (1014.99) (1098.29)   (4136.54) (3653.33)
4  Other Income    - -   - -   - -   - -
5 Profit / (Loss) before Interest and Exceptional Items (3+4)   (914.67) (511.92)   (3749.70) (3203.23)   (1014.99) (1098.29)   (4136.54) (3653.33)
6  Interest     165.30 175.92   623.12 356.59   168.77 175.92   626.59 356.59
7 Profit / (Loss) after Interest but before Exceptional Items (5-6)   (1079.96) (687.84)   (4372.81) (3559.82)   (1183.76) (1274.21)   (4763.13) (4009.92)
8 Exceptional Items - Income/(Expense)   - -   - -   - -   - -
9 Profit / (Loss) from Ordinary Activities before Tax (7-8)   (1079.96) (687.84)   (4372.81) (3559.82)   (1183.76) (1274.21)   (4763.13) (4009.92)
10 Tax Expense                         
  - Current period   - -   - -   6.13 2.68   6.13 2.68
  - Earlier period   (74.52) -   (74.52) -   (74.52) - - (74.52) -
11 Profit / (Loss) from Ordinary Activities after Tax (9-10)   (1005.44) (687.84)   (4298.29) (3559.82)   (1115.37) (1276.89)   (4694.74) (4012.60)
12 Extraordinary Items-Income/(Expense)   - -   - 3385.77   - -   - 3385.77
13 Net Profit /(Loss) for the period     (1005.44) (687.84)   (4298.29) (174.05)   (1115.37) (1276.89)   (4694.74) (626.83)
14 Share of Minority Interest   - -   - -   (0.31) (5.13)   (0.31) (5.13)
15 Profit after Tax and Minority Interest   (1005.44) (687.84)   (4298.29) (174.05)   (1115.06) (1271.76)   (4694.43) (621.70)
16 Paid-up Equity Share Capital of Face Value of Rs.2/- each   8995.86 8995.86   8995.86 8995.86   8995.86 8995.86   8995.86 8995.86
17 Reserves excluding Revaluation reserves   - -   24275.49 24275.49   - -   24275.49 24275.49
18 a) Earning Per Share before Extraordinary Items (in Rs.) -                                        
  Basic & Diluted   (0.22) (0.15)   (0.96) (0.86)   (0.25) (0.31)   (1.04) (0.96)
  b) Earning Per Share after Extraordinary Items (in Rs.) -                                                           
  Basic & Diluted   (0.22) (0.15)   (0.96) (0.04)   (0.25) (0.31)   (1.04) (0.15)
19 Public Shareholding                        
  - Number of Shares   294454615 294454615   294454615 294454615   294454615 294454615   294454615 294454615
  - Percentage of shareholding   65.46% 65.46%   65.46% 65.46%   65.46% 65.46%   65.46% 65.46%
20 Promoters and Promoter Group Shareholding                        
  a) Pledged / Encumbered                        
  - Number of Shares   610000 610000   610000 610000   610000 610000   610000 610000
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group)   39.00% 39.00%   39.00% 39.00%   39.00% 39.00%   39.00% 39.00%
  - Percentage of shares (as a % of the total share capital of the company)   14.00% 14.00%   14.00% 14.00%   14.00% 14.00%   14.00% 14.00%
  b) Non-encumbered                        
   - Number of Shares   154761588 154761588   154761588 154761588   154761588 154761588   154761588 154761588
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group)   99.61% 99.61%   99.61% 99.61%   99.61% 99.61%   99.61% 99.61%
  - Percentage of shares (as a % of the total share capital of the company)   34.40% 34.40%   34.40% 34.40%   34.40% 34.40%   34.40% 34.40%
Notes:                          
1. The above results, after approval by audit committee and audited by Statutory Auditors of the company have been taken on record by Board of Directors at its meeting held on 13th May, 2011.
2. The Company is exclusively engaged in the Pharmaceutical Business segment.
3. There were no investor complaints pending at the beginning of the quarter. During the quarter, 07 shareholder's complaints were received and resolved.
4. Statement of assets and liabilities as on 31.03.2011.
                (Rs. in Lacs)      
  Particulars   Standalone   Consolidated      
    (Audited)   (Audited)      
    Year ended   Year ended      
    31.03.2011 31.03.2010   31.03.2011 31.03.2010      
  SHAREHOLDERS' FUNDS                        
  (a) Share Capital         20961.07 20961.07   20961.07 20961.07      
  (b) Reserves and Surplus         24275.49 24275.49   24275.49 24275.49      
  LOAN FUNDS           14204.58 13973.95   14204.58 13973.95      
  TOTAL           59441.14 59210.51   59441.14 59210.51      
  FIXED ASSETS           41658.24 45838.87   49601.63 54018.12      
  INVESTMENTS           12190.92 12190.92   396.55 396.55      
  CURRENT ASSETS, LOANS AND ADVANCES                        
  Inventories         3360.50 3046.57   3470.73 3168.42      
  Sundry Debtors         2773.44 2056.79   2963.98 2383.18      
  Cash and Bank Balances         233.61 82.39   258.18 110.29      
  Loans and Advances         1241.87 1261.42   1320.03 1333.75      
              7609.42 6447.17   8012.92 6995.64      
  Less : CURRENT LIABILITIES & PROVISIONS                  
  Current Liabilities         9268.46 8315.13   9186.27 8217.58      
  Provisions         388.39 306.34   388.39 306.34      
  NET CURRENT ASSETS         (2047.43) (2174.30)   (1561.74) (1528.28)      
  MINORITY INTEREST               43.86 43.82      
  MISCELLANEOUS EXPENDITURE         128.48 142.38   128.48 142.38      
  (To the extent not written off /adjusted)                        
  PROFIT & LOSS ACCOUNT (DEBIT BALANCE)         7510.93 3212.64   10832.36 6137.93      
  TOTAL           59441.14 59210.51   59441.14 59210.51      
                             
                      For and on behalf of the Board
                             
                             
Place: New Delhi                       (Sushil Suri)
Date: 13.05.2011 Chairman & Managing Director